PURPOSE: 65% of registration proceeds will go towards the ROAR campaign to renovate vacant & abandon Baltimore homes for families, in need.
WHEN: Tuesday, October 20, 2015 | 6:30pm-8:30pm
WHERE: Johns Hopkins East, 1101 East 33rd Street, Baltimore, Maryland 21218 | 3rd Floor Conference Room.
PRESENTER: Dr. Jayfus Tucker Doswell | President/CEO Juxtopia
When it comes to capturing venture capital funding Maryland tops the region in both deals and dollars.
In a ranking of all 50 states and D.C., Maryland ranked No. 11 in venture capital funding in the third quarter of 2015. It ranked No. 7 in its share of nationwide deals during the same time.
The U.S. Department of Commerce’s Commercial Service is coordinating participation in the Hannover Messe, the world’s largest Industrial Trade Fair, to be held in April 25-29, 2016 in Hannover, Germany. This year, the United States is the official partner country for the first time and therefore will offer substantial visibility to U.S. based exhibitors who participate in any of the five trade shows, including one for Research and Technology, as well as an Investment Pavilion.
The Research & Technology trade show would be a great platform for U.S. Exhibitors, including Large and Start-up Companies, Academia, Technical Institutions, and Labs, to present their research activities in these fields .
AstraZeneca and Peregrine are expanding their ongoing onco-immunotherapy pact to allow for a Phase II trial of an experimental lung cancer combination treatment.
The companies said they will test a combination of Peregrine’s phosphatidylserine-targeted immune-activator bavituximab and AZ’ anti-PD-L1 immune checkpoint inhibitor durvalumab (MEDI4736) in a global Phase II study in patients with previously treated squamous or non-squamous non-small cell lung cancer.
M Square, the University of Maryland Research Park, won this year’s Association of University Research Parks’ Outstanding Research Park award.
The award ceremony took place earlier this month during the AURP Annual Awards of Excellence at the Buffalo Niagara Medical Campus in New York.
Silver Spring-based United Therapeutics Corp. on Thursday announced its board had authorized the repurchase of up to an additional $500 million worth of its common stock, for as long as a year, starting Jan. 1. Purchases may be made in the open market or in privately negotiated transactions from time to time as determined by the …
An entrepreneur as well as a scientist, Kunal Parikh has spent years developing drug-delivery platforms to improve patient treatment. He plans to spend the next year pursuing patents for these technologies; submitting his research for publication in scholarly journals; visiting hospitals and manufacturing plants to conduct implementation research; and continuing to lead and mentor the team of scientists, engineers, and clinicians who work alongside him.
One year doesn’t seem like enough time.
The kind of opportunity that technology and energy markets once offered is beckoning investors to property near biotech clusters. Emerging from the recession, technology and energy markets commanded the attention of commercial real-estate investors that wanted to tap into improving occupancy and rental rates largely absent elsewhere.
A similar dynamic is germinating in biotech clusters, which are typically marked by a high concentration of life-science companies near academic research institutions.
Trade-Ideas LLC identified Sucampo Pharmaceuticals ( SCMP) as a “dead cat bounce” (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Sucampo Pharmaceuticals as such a stock due to the following factors:
Join us Nov. 19 for the 16th annual Bioscience Day at the University of Maryland, where we’ll explore “Systems Biology: Advancing Life Sciences and Medicine.”
Registration is free and lunch is provided.
